Good news: Obesity rates are going down thanks to novel anti-obesity treatments around GLP-1 agonists. Diabetes Type 2 can be combatted. How can current manufacturing bottlenecks and access barriers for...
I was listening to an episode of the Cheeky Pint podcast with John and Patrick Collison, where they interviewed Dave Ricks, the CEO of Eli Lilly. There was a section...
Berlin/Köln, 31. Oktober 2025. Das Landgericht Köln hat die Vermittlung von Fahrten über UberX in der beanstandeten Version untersagt – mit Ordnungsgeldern bis zu 250.000 Euro je Verstoß oder Ordnungshaft....
Emil Panzaru and I recently published in Economic Affairs Volume 45, Issue 3 “Societal value and health economic benefits of GLP-1 drugs in the United States” and today Institute for...
A recent Consumer Choice Center (CCC) report outlines the ongoing risks linked to compounded GLP-1 products and the actions policymakers should take to ensure patient safety. The report adds to the growing industry concern...
Die Europäische Kommission spielt ein gefährliches Doppelspiel. Laut einem Bericht der Bild-Zeitung will sie sich bei der kommenden WHO-Tabakkonferenz (COP11) im November für ein Verbot von Filterzigaretten einsetzen. Grundlage ist...
WASHINGTON, D.C. – Today, the CONSUMER CHOICE CENTER (CCC) released a new policy primer titled GLP-1 Agonists, Intellectual Property, and the Hidden Dangers of Compound Drugs to American Consumers, documenting...
Neue Rauch-Regeln aus Brüssel sorgen für Wirbel: Die Europäische Union will den Tabakkonsum stärker einschränken – und das könnte für viele Raucherinnen und Raucher spürbare Folgen haben. Ein offizielles „Zigarettenverbot“...
When it comes to access to life-changing new medicines, the UK is becoming increasingly isolated and not in a good way. Patients here face a rigid system that denies them...
In May 2025, the White House announced a ‘Most Favored Nation’ approach for setting prescription drug prices. The order aims to align U.S. prices with those paid in peer countries and directs...
For the first time, there is real hope in the fight against obesity. New datafrom the Centers for Disease Control and Prevention’s National Center for Health Statistics shows that adult obesity...
Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from enabling innovation to second-guessing it. Alongside figures like Robert F. Kennedy...